Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥102.7bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥184.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥88.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥13.6bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥10.9bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥16.6bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥23.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥11.8bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥16.4bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥13.0bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥11.3bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥11.3bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥9.3bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥329.5bnat 2022-09-30Cons.Assets
Total assets¥315.5bnat 2022-03-31Cons.Assets
Total assets¥302.0bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥70.3bnat 2022-09-30Cons.Liabilities
Total liabilities¥69.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥259.2bnat 2022-09-30Cons.Net assets
Net assets / equity¥246.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥233.5bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥41.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥38.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥52.6bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥53.0bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥50.4bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥47.5bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥12.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥14.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥6.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥11.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥67.042022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.632022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.272021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.352021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥67.022022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥101.652021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥54.262021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio78.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥4.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥55m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥899m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥137m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥137m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥3.7bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue2022-04-01 → 2022-09-30¥46.1bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue external2022-04-01 → 2022-09-30¥46.0bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥82m
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentsegment profit2022-04-01 → 2022-09-30¥7.8bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue external2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E00836-000Medicinereportable segmentsegment profit2022-04-01 → 2022-09-30¥4.5bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue2022-04-01 → 2022-09-30¥26.7bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue external2022-04-01 → 2022-09-30¥26.7bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.0bn
—segment totalrevenue2022-04-01 → 2022-09-30¥98.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥98.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥82m
—segment totalsegment profit2022-04-01 → 2022-09-30¥16.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥102.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥102.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥137m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥17.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥4.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥4.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥51m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥919m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥123m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥123m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥3.4bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue2021-04-01 → 2021-09-30¥37.7bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue external2021-04-01 → 2021-09-30¥37.6bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥71m
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentsegment profit2021-04-01 → 2021-09-30¥6.1bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue external2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥0
jpcrp040300-q2r_E00836-000Medicinereportable segmentsegment profit2021-04-01 → 2021-09-30¥4.1bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue2021-04-01 → 2021-09-30¥21.6bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue external2021-04-01 → 2021-09-30¥21.6bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentsegment profit2021-04-01 → 2021-09-30¥3.2bn
—segment totalrevenue2021-04-01 → 2021-09-30¥84.8bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥84.8bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥71m
—segment totalsegment profit2021-04-01 → 2021-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥89.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥88.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥123m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥14.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 583
ItemContextValueUnit
Cost of salesCurrentYTDDuration66988000000JPY
Gross profitPrior1YTDDuration31218000000JPY
Gross profitCurrentYTDDuration35740000000JPY
Selling general and administrative expensesPrior1YTDDuration20315000000JPY
Selling general and administrative expensesCurrentYTDDuration22180000000JPY
Operating incomePrior1YTDDuration10902000000JPY
Operating incomeCurrentYTDDuration13559000000JPY
Interest income noiPrior1YTDDuration63000000JPY
Interest income noiCurrentYTDDuration231000000JPY
Dividends income noiPrior1YTDDuration544000000JPY
Dividends income noiCurrentYTDDuration510000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration245000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration6000000JPY
Foreign exchange gains noiPrior1YTDDuration-JPY
Foreign exchange gains noiCurrentYTDDuration2114000000JPY
Other noiPrior1YTDDuration396000000JPY
Other noiCurrentYTDDuration439000000JPY
Non operating incomePrior1YTDDuration1249000000JPY
Non operating incomeCurrentYTDDuration3301000000JPY
Interest expenses noePrior1YTDDuration39000000JPY
Interest expenses noeCurrentYTDDuration41000000JPY
Foreign exchange losses noePrior1YTDDuration122000000JPY
Foreign exchange losses noeCurrentYTDDuration-JPY
Other noePrior1YTDDuration161000000JPY
Other noeCurrentYTDDuration191000000JPY
Non operating expensesPrior1YTDDuration323000000JPY
Non operating expensesCurrentYTDDuration232000000JPY
Ordinary incomePrior1YTDDuration11828000000JPY
Ordinary incomeCurrentYTDDuration16628000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1372000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration31000000JPY
Gain on sales of investment securities eiPrior1YTDDuration81000000JPY
Gain on sales of investment securities eiCurrentYTDDuration-JPY
Extraordinary incomePrior1YTDDuration1453000000JPY
Extraordinary incomeCurrentYTDDuration31000000JPY
Loss on disposal of noncurrent assets elPrior1YTDDuration252000000JPY
Loss on disposal of noncurrent assets elCurrentYTDDuration211000000JPY
Loss on valuation of investment securities elPrior1YTDDuration57000000JPY
Loss on valuation of investment securities elCurrentYTDDuration3000000JPY
Extraordinary lossPrior1YTDDuration309000000JPY
Extraordinary lossCurrentYTDDuration214000000JPY
Income before income taxesPrior1YTDDuration12972000000JPY
Income before income taxesCurrentYTDDuration16445000000JPY
Income taxes currentPrior1YTDDuration3225000000JPY
Income taxes currentCurrentYTDDuration4456000000JPY
Income taxes deferredPrior1YTDDuration495000000JPY
Income taxes deferredCurrentYTDDuration664000000JPY
Income taxesPrior1YTDDuration3720000000JPY
Income taxesCurrentYTDDuration5120000000JPY
Profit lossPrior1YTDDuration9251000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass